MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 129 filers reported holding MACROGENICS INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,000 | +87.5% | 756 | -41.8% | 0.00% | – |
| Q4 2019 | $8,000 | +14.3% | 1,300 | -18.8% | 0.00% | – |
| Q3 2019 | $7,000 | +40.0% | 1,600 | -92.6% | 0.00% | – |
| Q2 2019 | $5,000 | -50.0% | 21,700 | +4.8% | 0.00% | -100.0% |
| Q1 2019 | $10,000 | – | 20,700 | +3350.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 600 | -33.3% | 0.00% | – |
| Q1 2018 | $4,000 | -73.3% | 900 | +12.5% | 0.00% | -100.0% |
| Q4 2017 | $15,000 | -40.0% | 800 | -89.0% | 0.00% | 0.0% |
| Q3 2017 | $25,000 | -50.0% | 7,300 | -31.3% | 0.00% | -50.0% |
| Q2 2017 | $50,000 | -39.0% | 10,620 | +99.4% | 0.00% | -33.3% |
| Q1 2017 | $82,000 | -21.9% | 5,327 | -11.4% | 0.00% | -25.0% |
| Q4 2016 | $105,000 | +183.8% | 6,012 | -4.6% | 0.00% | +300.0% |
| Q3 2016 | $37,000 | -54.3% | 6,300 | -20.6% | 0.00% | -75.0% |
| Q2 2016 | $81,000 | -63.3% | 7,931 | -65.4% | 0.00% | -71.4% |
| Q1 2016 | $221,000 | +750.0% | 22,900 | +2.7% | 0.01% | +1300.0% |
| Q4 2015 | $26,000 | – | 22,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |